Simone Krebs Laboratory
@LabKrebs
We focus on the development of imaging and theranostic agents including in vivo tracking methods of adoptively transferred cells for cancer therapy.
Bunları beğenebilirsin
The Illustrated Post: Symptomatic PSMA PET–positive radionecrosis after multimodality brain metastasis–directed treatment including ¹⁷⁷Lu-PSMA-617. ow.ly/5sra50Vjv05 #RPTherapy #NuclearMedicine #BrainMetastases @LabKrebs @brandon_imber @mskCancerCenter
Join the European Molecular Imaging Meeting, March 11-14, 2025 in Bilbao, ES! Submissions are already possible with deadline 19 November 2024. We can't wait to see you next spring in beautiful Bilbao!
Submit your abstract for #WMIC2024 and be considered for prestigious awards that recognize your work and support your attendance! 🏆 Young Investigator: Up to $2,000 ✈️ Travel Stipends: Up to $800 🖼️ Poster Awards: $250 🔬 Interest Group Awards Details: wmis.org/wmic-2024-abou…
Dr. Simone Krebs @LabKrebs winning the Saul Hertz Young Investigator Award at Theranostics 2024. @MSKCancerCenter #theranostics #TWC2014
Our latest article in @JournalofNucMed reviewing the role of nuclear imaging approaches for improved diagnosis of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. @StanfordMIPS, @FedeSimonetta
Molecular imaging of acute graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation has great potential to detect GvHD at the early stages. ow.ly/fi0R50QGiQm #MolecularImaging #HSCT #NuclearMedicine @Israt_Alam
Dear Colleagues, the abstract system has been just re-opened for late-breaking submissions to the EMIM meeting in Porto – with deadline on Thursday 25 January 2024! Don't miss this last chance and/or encourage your colleagues to submit. Just proceed to emim.eu.
Dear Colleagues, In my capacity as Program Chair, I would like to bring the upcoming EMIM 2024 to your attention: The deadline for abstract submission is 21 November 2023 via emim.eu. We can't wait to see you next spring in beautiful Porto!
Our paper is out! We present a versatile platform enabling monitoring of CAR-T cells in vivo using PET, as well as providing selective delivery of therapeutic radioisotopes to increase anti-tumor efficacy. Great team work! @DASLab_MSKCC thno.org/v13p5469.htm #Theranostics
⁶⁸Ga-pentixafor PET may guide CXCR4-based theranostic approaches with pentixather in selected #meningioma. ow.ly/bZKY50NAtB9 #PETscan #Theranostics @LabKrebs
Using blood-based #biomarkers to determine the efficacy of ¹⁷⁷Lu-DOTATATE in #NeuroendocrineTumors. ow.ly/4PAF50NAttU #NuclearMedicine #MedicalResearch #NETCancer @lisabodei @DianeReidyLagun @LabKrebs @amauguen @DrRichardDo
@LabKrebs We have an open postdoc position. Are you interested in molecular imaging and therapy (theranostic) and adoptive T cell therapy? Motivated to work in a highly interactive, interdisciplinary and rewarding environment? Then check us out! mskcc.org/research-areas…
@LabKrebs Huge congratulations to Laura Eibler for receiving the 1st Place price in Basic Track for her abstract & 1st Place Center for Molecular Imaging Innovation & Translation Young Investigator Award at the SNMMI 2022!! And kudos to the entire team! @DASLab_MSKCC Larson Lab
Fantastic talk by @emma_reynaud99 wrapping up months of amazing work imaging CAR T cells in action diagnosing & treating cancers @MSKCancerCenter @LabKrebs @DASLab_MSKCC @SchuringaJan Larsonlab #theranostics
United States Trendler
- 1. Thanksgiving 2.25M posts
- 2. Lions 89.9K posts
- 3. Dan Campbell 6,044 posts
- 4. #GoPackGo 9,725 posts
- 5. Wicks 9,528 posts
- 6. Jordan Love 12.6K posts
- 7. Micah Parsons 7,249 posts
- 8. Goff 10.6K posts
- 9. Jack White 8,285 posts
- 10. Watson 14.6K posts
- 11. #GBvsDET 4,548 posts
- 12. #OnePride 6,724 posts
- 13. Jamo 4,902 posts
- 14. Gibbs 8,722 posts
- 15. Jameson Williams 2,571 posts
- 16. Matt LaFleur 2,344 posts
- 17. Thankful 459K posts
- 18. Turkey 289K posts
- 19. Brian Branch N/A
- 20. Wyatt 5,507 posts
Something went wrong.
Something went wrong.